Related Experiment Video

Updated: Feb 5, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K

One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy

Elias J Dayoub1, Hema Datwani2, Jennifer Lewey3

  • 1Division of General Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Leonard Davis Institute of Health Economics at the University of Pennsylvania, Philadelphia, Pennsylvania; Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, Pennsylvania.

Journal of Cardiac Failure
|September 9, 2018
PubMed

Insights

Women surviving peripartum cardiomyopathy (PPCM) face significant cardiovascular risks, including blood clots and heart failure, one year after delivery. These PPCM complications highlight the need for ongoing monitoring and care.

Area of Science:

  • Cardiology
  • Obstetrics
  • Public Health

Background:

  • Peripartum cardiomyopathy (PPCM) is a significant cause of maternal morbidity.
  • Limited large-scale studies exist on long-term cardiovascular outcomes for PPCM survivors.
  • This study investigates cardiovascular outcomes in PPCM survivors beyond the immediate postpartum phase.

Purpose of the Study:

  • To examine the cardiovascular outcomes of 1-year survivors of peripartum cardiomyopathy (PPCM).
  • To compare the incidence of major adverse cardiovascular events (MACEs) in PPCM survivors versus a matched control group.

Main Methods:

  • Retrospective cohort study using administrative claims data (2005-2012).
  • Inclusion of 975 women aged 15-54 with PPCM, matched to controls without cardiovascular complications.
  • Analysis of cardiovascular complications from 11 to 365 days post-delivery.

Main Results:

  • PPCM survivors experienced higher rates of major adverse cardiovascular events (MACEs) compared to controls (6.3% vs 0.6%).
  • Most common MACEs in PPCM survivors at 1 year included venous thromboembolism (2.2%), heart failure hospitalization (1.6%), and atrial fibrillation (1.0%).
  • Significant differences in MACE incidence were observed between the PPCM and control groups (P < .001).

Conclusions:

  • Peripartum cardiomyopathy survivors face substantial ongoing morbidity one year post-delivery.
  • Venous thromboembolism and subsequent heart failure hospitalizations are the most frequent complications.
  • These findings underscore the importance of continued cardiovascular surveillance for PPCM patients.
Abstract

Keywords:
Peripartum cardiomyopathyatrial fibrillationoutcomes researchvenous thromboembolism

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
496
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
552
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
459
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
611
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
358